
Circulating tumor DNA (ctDNA) testing holds significant potential to improve outcomes for colorectal cancer patients by enabling early detection of minimal residual disease, guiding adjuvant therapy decisions, and monitoring treatment response.


coremsg

Are you using liquid biopsies in your practice? Drs Benjamin Schlechter and Pashtoon Kasi discuss the latest clinical applications of ctDNA and liquid biopsies in colorectal cancer.

S2 Episode 1: Tumor Trash or Treasure? Liquid Biopsy for Colorectal Cancer

circulating-tumor-dna-a-promising-tool-for-monitoring-and-guiding-colorectal-cancer-treatment


Circulating Tumor DNA: A Promising Tool for Monitoring and Guiding Colorectal Cancer Treatment
